Schistosomiasis: Put parasitic infections on the map
Wendy Harrison, CEO of the SCI Foundation, outlines the importance of putting parasitic infections on the map, with a particular focus on schistosomiasis.
Early Alzheimer’s disease detection sensor in development
Researchers are developing a new Alzheimer's disease detection sensor that can be used in the early stages of Alzheimers and a number of other diseases.
Degenerative eye disease and the opportunities of ophthalmic drug development
Eric Buckland of Translational Imaging Innovations looks at ophthalmic drug development and how better clinical endpoints can improve success rates.
What is the optimal window for the early detection of Alzheimer’s disease?
Dr. Gerardo Fernandez, CSO ViewMind Inc, investigates how early is too early for the detection of Alzheimer’s disease and how soon in the disease’s trajectory detection can make a meaningful difference in a patient’s prognosis.
Allergic asthma and the legacy of structural racism on the African American urban communities
Asthma is a chronic inflammatory disease that is characterized by bronchial hyperreactivity (wheezing due to narrowing of the airways) and it disproportionately affects African Americans.
Reducing the burden of cardiovascular diseases in Africa
Dr Prebo Barango and Prof Jean-Marie Dangou from the WHO Regional Office for Africa argue that reducing the burden of cardiovascular diseases in Africa is imperative.
Understanding diabetes: Reducing the risk of type 2
Dr Stacey Lockyer, Senior Nutrition Scientist at the British Nutrition Foundation, walks us through understanding diabetes & reducing the risk of type 2 diabetes.
New drug ‘Lecanemab’ slows the effects of Alzheimer’s disease
After decades of failure for Alzheimer’s researchers, Lecanemab could open the door to a new ear of drugs to treat Alzheimer’s disease – the world's most common form of dementia.
Could beer hops give insight into treating Alzheimer’s?
Beer hops have been found to provide unique health benefits for Alzheimer’s disease, preventing the clumping of amyloid beta proteins.
Personalising genome sequencing doubles the diagnosis of rare diseases
Implementing personalising genome sequencing and tailoring analysis to each individual patient could double diagnostic rates of rare diseases.
Infection prevention and control: including technology
Dr Zisis Kozlakidis directs our thoughts towards infection prevention and control, including technology, in his two-part series.
COVID-19 causes brain inflammation similar to Parkinson’s disease
COVID-19 activates the same inflammatory response in the brain as Parkinson’s disease – increasing the risk of future potential neurodegenerative conditions.
The expansion of potential Alzheimer’s drugs
Alzheimers drugs have been shown able to target insulin receptors located in cerebral microvessels, massively expanding the future of drug production and testing
Osteoporosis: An important NCD component of WHO’s vision for healthy ageing
World Health Organization, Regional Office for the Eastern Mediterranean, describes what we need to know about osteoporosis prevention, management and treatment, an integral component of their vision for healthy ageing.
Diabetes education to protect tomorrow
Prof Andrew Boulton, President, International Diabetes Federation, calls for more to be done to improve access to diabetes education.
Peripheral neuropathy: Tracking gait and biomarkers to keep feet healthy and whole
Novel smart insole solution helps people with diabetes ensure foot health, by preventing peripheral neuropathy ulcers and falls.
Unlocking life-changing dementia treatments
Is better diagnosis the key to unlocking life-changing dementia treatments? Dr Susan Mitchell, Head of Policy at Alzheimer’s Research UK provides the answer.
The global picture of Tuberculosis: A view from WHO
Experts Dr Michel Gasana & Dr Frank Lule from World Health Organization – Regional Office for Africa, provide an update on the global picture of Tuberculosis.
Tickborne diseases: A growing health problem in the U.S.
Chief of the Bacterial Diseases Branch, Division of Vector-Borne Diseases at the Centers for Disease Control & Prevention, walks us through a growing health problem in the United States, tickborne diseases.
PAVE: Global research study on epidemiology of Alzheimer’s disease
To improve understanding of the impact and epidemiology of Alzheimer’s disease, Project Alzheimer’s Value Europe (PAVE) demonstrates the prevalence of Alzheimer’s across the stages of the disease, including prodromal and preclinical – which aren’t recognised by previous studies.